Roche Cooperates with Wellthy Therapeutics to Bring-in AI based Digital Diabetes Coaching Solution for Type 2 Diabetics
Facebook Twitter google+ RSS Feed

Roche Cooperates with Wellthy Therapeutics to Bring-in AI based Digital Diabetes Coaching Solution for Type 2 Diabetics

By SiliconIndia   |   Wednesday, 31 October 2018, 06:15 Hrs
45
cmt right
33
Comment Right
58
cmt right
13
cmt right
Printer Print Email Email


Roche Diabetes Care, a pioneer in diabetes technologies and services joined hands with the digital health company Wellthy Therapeutics, offering users of Accu-Chek Active System an innovative artificial intelligence-based digital diabetes coaching solution. The joint offering of the two companies will encompass the trusted Accu-Chek Active blood glucose meter and will address the urgent need for support in daily therapy management. The remote coaching will offer people with diabetes together with their healthcare professionals an affordable new way to continuously keep blood glucose levels in range in-between doctors’ visits while achieving improved adherence and outcomes.



Rahul Kedia, Ad-Interim General Manager, Roche Diabetes Care, says, “India is home to the second largest number of people living with diabetes in the world, numbering about 73 million in 2017 as per the International Diabetes Federation. There is a real need for those patients to be able to monitor their blood glucose levels regularly and be supported in their efforts to keep their diabetes under control. With Wellthy’s digital diabetes health coach, new Accu-Chek Active users can log blood glucose readings into the app to receive 24/7 guidance on understanding and managing their diabetes better. We firmly believe that this joint offering will help in improving the quality of life for Indians living with type 2 diabetes”.



Wellthy Therapeutics’s first digital therapeutic for Type II diabetes has been endorsed by the RSSDI, Asia’s largest diabetes association. It inspires and enables patients to prevent, reverse and control their chronic disease. Abhishek Shah, Co-Founder & CEO, Wellthy Therapeutics, comments, “Roche Diabetes Care shares our vision for digital therapeutic solutions that work alongside point of care diagnostics to achieve superior patient outcomes. We are excited about this partnership, as it gives people living with diabetes access to our clinically validated diabetes therapeutic to improve and manage their health. This partnership marks an important first step, in a larger shared vision to make a meaningful difference to the lives of millions of people living with this chronic disease”.



Being a global leader in integrated diabetes management, Roche Diabetes Care collaborates with caregivers, healthcare providers and payers to optimally manage this complex condition and contribute to sustainable care structures. It aims to improve patients’ access to medical innovations by working with all relevant stakeholders. Headquartered in Basel, the Roche Group is active in over 100 countries and in 2017 employed about 94,000 people worldwide.



Read more news:



Mumbai leads data centre business, Bengaluru 2nd: Report



How to tackle XAT Decision Making



Write your comment now
Submit Reset
SPOTLIGHT